Sabra Health Care REIT (SBRA) Gains from Investment Securities (2013 - 2026)

Sabra Health Care REIT's Gains from Investment Securities history runs 9 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Gains from Investment Securities fell 30.03% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $7.1 million (up 12.07% YoY), while the FY2025 annual figure was $7.8 million, up 43.44% from the prior year.
• Gains from Investment Securities for Q1 2026 stood at $1.7 million, down from $1.9 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $2.4 million in Q1 2025, with the low at $367000.0 in Q1 2023.
• The 4-year median for Gains from Investment Securities is $1.7 million (2025), against an average of $1.4 million.
• The sharpest annual moves came in 2024 and 2026: Gains from Investment Securities surged 302.72% in 2024, then plunged 30.03% in 2026.
• Sabra Health Care REIT's Gains from Investment Securities stood at $1.8 million in 2023, then dropped by 4.02% to $1.7 million in 2024, then advanced by 11.99% to $1.9 million in 2025, then decreased by 12.61% to $1.7 million in 2026.
• Business Quant data shows SBRA's Gains from Investment Securities at $1.7 million in Q1 2026, $1.9 million in Q4 2025, and $1.9 million in Q3 2025.